Rallybio Corp (RLYB) Form 8-K — Sep 9, 2026
Rallybio (RLYB) disclosed that CFO Jonathan Lieber will transition to part-time employment status effective September 15, 2026, while remaining Chief Financial Officer and Principal Financial Officer with the same duties and authority. Under the Employment Side Letter, Lieber will receive a $420,000 annualized base salary and retain benefits eligibility, but will forfeit annual bonuses for 2026 and any subsequent year; he also waived any right to resign for Good Reason over the compensation changes.
Key figures
- Annual Bonus Waived
- 2026 and all subsequent years of employment
- Part Time Base Salary
- 420000
- Employment Transition Date
- September 15, 2026 (or later of completion of the first S-4 amendment filing)
- Employment Termination Trigger
- closing of the pending Avenzo Therapeutics business combination
- Post Closing Option Exercise Window
- 90 days following merger closing
Price after filing
Close on the filing date to close N calendar days later (from $16.97). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.